P-3075

a cream based on 5% potassium azeloyl diglycinate and 1% hydroxypropyl chitosan

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

1.	Abril, Elva: 1 article (03/2012)
2.	Berardesca, Enzo: 1 article (03/2012)
3.	Caserini, Maurizio: 1 article (03/2012)
4.	Guglielmini, Giancarlo: 1 article (03/2012)
5.	Iorizzo, Matilde: 1 article (03/2012)
6.	Palmieri, Renata: 1 article (03/2012)
7.	Piérard, Gérald E: 1 article (03/2012)

1.	Erythema 03/01/2012 - " The P-3075 cream applied for 28 days was effective in skin protection by reducing erythema, evaluated both instrumentally and clinically. "
2.	Rosacea (Acne Rosacea) 03/01/2012 - "Forty-two patients (rosacea stages I and II) were enrolled and randomized, 28 in the P-3075 group and 14 in the placebo group. "
3.	Flushing 03/01/2012 - "In addition, the clinical assessments of other symptoms such as flushing, stinging, and burning supported the beneficial effect of the P-3075 cream. "